MORGAN UNSER: Open Payments
NPI 1427833722 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,215 in 194 payments from 19 companies in 2025. Trend: 2023 $789 · 2024 $4,408 · 2025 $4,215
Food & beverage: $4,203Education: $12
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $594 |
| ABBVIE INC. | 30 | $553 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $438 |
| Vanda Pharmaceuticals Inc. | 9 | $367 |
| Teva Pharmaceuticals USA, Inc. | 17 | $329 |
| Neurocrine BioSciences, Inc. | 11 | $298 |
| Axsome Therapeutics, Inc. | 17 | $297 |
| Alkermes, Inc. | 22 | $283 |
| Janssen Pharmaceuticals, Inc | 6 | $207 |
| Corium, LLC | 12 | $204 |
Products named: VRAYLAR, REXULTI, CAPLYTA, FANAPT, INGREZZA, Auvelity, ARISTADA, Azstarys.
Industry payments across LA — which companies pay providers there.
